Medifarmsoft, founded in 2018, is a specialized company that develops and provides intelligent biometric information analysis platforms based on the convergence of medical devices and IT technology. In 2021, we developed a personal electrocardiogram (ECG) self-diagnostic device called CAI-100, which applies an AI algorithm to display rapid and accurate ECG analysis results. This allows both medical institutions and the general public, including those with heart disease, to easily conduct ECG tests anytime, anywhere. The test results can be monitored in real-time through a mobile application and WEB-Viewer software, and the product is revolutionary in that medical doctors can diagnose remotely gathered data in real-time. In addition, Medifarmsoft plans to provide opportunities for early detection and treatment of arrhythmia in heart disease patients through the development of a 6-lead Holter ECG (CAI-300) and an AI-based 12-lead ECG reading system for predicting atrial fibrillation (PAPS). In the future, Medifarmsoft will continue to work tirelessly to develop and improve biometric information analysis medical devices and IT software, and contribute to creating a healthy society by becoming a leading company in the AI-based biometric information analysis platform industry.